Houlihan Lokey Advises AllDent Holding
AllDent, a portfolio company of funds managed by Castik Capital, has completed a debt refinancing
Financing Advisor
Houlihan Lokey is pleased to announce that AllDent Holding GmbH (AllDent), a portfolio company of funds managed by Castik Capital S.à r.l. (Castik), has completed a debt refinancing. Houlihan Lokey served as the exclusive financing advisor to AllDent on the transaction, which closed on 28 November 2025.
AllDent is a leading dental services provider in Germany, operating under the AllDent Zahnzentrum brand. Established in 2011 and headquartered in Munich, the company delivers a broad range of dental services, including preventive care, cosmetic dentistry, oral surgery, and emergency treatment. Through its network of modern clinics in major cities such as Munich, Frankfurt, Stuttgart, and Berlin, AllDent provides high-quality, accessible dental care, supported by a strong focus on delivering a high standard of patient care.
AllDent operates 20 large-format practices under a unified brand, delivering a consistent and standardised patient experience across its network. As the only major dental operator in Germany focused exclusively on greenfield expansion, AllDent is well-positioned to achieve sustainable growth while minimising execution risk. The company intends to continue expanding its footprint nationwide through this strategy, supported by a comprehensive service offering and fully standardised clinics that ensure consistent quality of care and attract new patients. In addition, AllDent offers a strong value proposition for employed dentists, combining competitive pay with clear career progression pathways.
Founded in 2014, Castik is a private equity investment manager focused on investing in high-quality and growing businesses headquartered in Europe and led by strong management teams and founders. Current investments are made by the Luxembourg-based fund, EPIC III, the third fund managed by Castik, which had its final fund close at €2 billion in September 2024.
RELATED: Healthcare, Capital Solutions